US Patent 7825267 Synthesis of FR901464 and analogs with antitumor activity
Patent 7825267 was granted and assigned to University of Pittsburgh on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+307 characters)
Article
Patent abstract
The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Ananthapadmanabhan Sivaramakrishnan0
Brian J. Albert0
Kazunori Koide0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07825267 Synthesis of FR901464 and analogs with antitumor activity US Patent 7825267 Synthesis of FR901464 and analogs with antitumor activity
Infobox
Patent Number
07825267
Patent Number
7825267
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07825267 Synthesis of FR901464 and analogs with antitumor activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07825267
Date of patent
November 2, 2010
Patent application number
11852278
Date Filed
September 8, 2007
Patent primary examiner
Find more entities like US Patent 7825267 Synthesis of FR901464 and analogs with antitumor activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
